C07C 323/52
The carbon skeleton being acyclic and saturated
Official title: the carbon skeleton being acyclic and saturated
C07C323/52 (The carbon skeleton being acyclic and saturated) appears on 611 US grants and 561 published applications in this corpus.
Search patents in C07C- Granted patents
- 611
- Published applications
- 561
- Assignees
- 376
- Inventors
- 1,702
- Latest grant
- 5 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 3 | 0 |
| 1977 | 8 | 0 |
| 1978 | 3 | 0 |
| 1979 | 5 | 0 |
| 1980 | 5 | 0 |
| 1981 | 1 | 0 |
| 1982 | 2 | 0 |
| 1983 | 1 | 0 |
| 1984 | 3 | 0 |
| 1985 | 1 | 0 |
| 1986 | 3 | 0 |
| 1987 | 1 | 0 |
| 1988 | 3 | 0 |
| 1989 | 4 | 0 |
| 1990 | 8 | 0 |
| 1991 | 13 | 0 |
| 1992 | 18 | 0 |
| 1993 | 22 | 0 |
| 1994 | 16 | 0 |
| 1995 | 13 | 0 |
| 1996 | 11 | 0 |
| 1997 | 10 | 0 |
| 1998 | 14 | 0 |
| 1999 | 17 | 0 |
| 2000 | 9 | 0 |
| 2001 | 15 | 0 |
| 2002 | 15 | 17 |
| 2003 | 13 | 23 |
| 2004 | 16 | 36 |
| 2005 | 15 | 35 |
| 2006 | 16 | 21 |
| 2007 | 14 | 25 |
| 2008 | 15 | 26 |
| 2009 | 15 | 26 |
| 2010 | 17 | 23 |
| 2011 | 20 | 21 |
| 2012 | 19 | 18 |
| 2013 | 19 | 28 |
| 2014 | 21 | 22 |
| 2015 | 27 | 20 |
| 2016 | 15 | 13 |
| 2017 | 18 | 27 |
| 2018 | 14 | 35 |
| 2019 | 24 | 21 |
| 2020 | 22 | 22 |
| 2021 | 17 | 16 |
| 2022 | 15 | 15 |
| 2023 | 9 | 22 |
| 2024 | 7 | 21 |
| 2025 | 12 | 17 |
| 2026 | 7 | 11 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- N-phenyl-3-mercaptopropanamide derivatives as metallo-beta-lactamase inhibitors for the treatment of bacterial infections5 May 2026US 12,616,670 B2Helmholtz-Zentrum FüR Infektionsforschung GmbH
- Semiconducting nanoparticle28 Apr 2026US 12,612,547 B2Samsung Electronics Co., Ltd.
- Profragrance conjugates31 Mar 2026US 12,590,264 B2International Flavors & Fragrances Inc.
- Compounds for a controlled release of active perfuming molecules24 Mar 2026US 12,584,082 B2Firmenich SA
- FABP4/5 inhibitors, methods of use and methods of making10 Mar 2026US 12,570,603 B2Celloram Inc.
- Method for quantitatively analyzing polysulfide in sample27 Aug 2026US 2026/0250239 A1Bio-Xcelerator, Inc.
- Process for treating keratin fibres using at least one oil bearing acetoacetate functions30 Jul 2026US 2026/0216024 A1L'oreal
- Perfluorinated micelles and medical uses thereof16 Jul 2026US 2026/0199236 A1Centre National De La Recherche Scientifique
- Combinatorial antitumor treatment methods and related compositions, kits, and systems9 Jul 2026US 2026/0191813 A1
- Processes for the Preparation of Alpha-Hydroxy Esters by an Acid Catalyzed Reaction of Alpha-Hydroxy Amides with Alcohols11 Jun 2026US 2026/0159477 A1Kemin Industries, Inc.
Most cited
By later US patents
- Mutilin derivatives and their use as antibacterials115US 7,534,814 B2Nabriva Therapeutics AG · 2009
- Pharmaceutical compositions and methods of inhibiting angiogenesis using naaladase inhibitors76US 6,395,718 B1Guilford Pharmaceuticals Inc. · 2002
- Benzoyl-substituted phenylalanineamides74US 7,687,435 B2BASF SE · 2010
- Thiopropionate synergists70US 5,672,730 AThe Goodyear Tire & Rubber Company · 1997
- N-aryl and N-heteroarylamide and urea derivatives as inhibitors of acyl coenzyme A: cholesterol acyl transferase (ACAT)69US 5,656,634 APfizer Inc. · 1997